Follow TPIMS:

  • Facebook: tpims
  • Linked In: company/torrey-pines-institute-for-molecular-studies
  • Twitter: tpims
  • External Link: plus.google.com/101737409313074589710/posts
  • Akron Biotech Awarded SBIR Grant for Development of Novel Method to Isolate Adipose Derived Stem Cells

    BOCA RATON, FLORIDA - Akron Biotech, an innovative biotech company focused on serving the growing demands of the cell therapy industry, is pleased to announce it was awarded a Phase 1 Small Business Innovative Research (SBIR) Award from the National Institutes of Health (NIH) to develop enzyme-based formulations for the isolation of stem cells from various tissues. The project is in collaborati ...

    Thursday, 17 April 2014
  • Florida Drug Discovery Acceleration Program

    FLORIDA DRUG DISCOVERY ACCELERATION PROGRAM The Florida Drug Discovery Acceleration Program is funded by the state of Florida for the 2013-2014 fiscal year through the Department of Health. This program allows for Torrey Pines Institute for Molecular Studies (TPIMS) to share its large collection of compound libraries and expertise to Florida Institutions to accelerate drug discovery and comme ...

    Thursday, 10 October 2013
  • IRSC and Torrey Pines Announce New Work-Study Internship Program

      Twenty students gain research experience Indian River State College (IRSC) and Torrey Pines Institute for Molecular Studies (TPIMS) have launched an innovative new Work-Study Internship program that engages students in cutting-edge bioscience research while they earn a paycheck and receive a $1,250 per semester scholarship at the same time.  The 20 students selected for the introduct ...

    Friday, 31 May 2013
  • Torrey Pines Institute for Molecular Studies Initiates Research Collaboration with Takeda

      Torrey Pines Institute for Molecular Studies, a non-profit institute dedicated to conducting basic research to advance the understanding of human disease and the improvement of human health, announced today the initiation of a research collaboration with Envoy Therapeutics, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. Torrey Pines Institute will supply Envoy with co ...

    Thursday, 17 January 2013
  • National Academy of Inventors and Torrey Pines Institute for Molecular Studies announce NAI Charter Fellows

    Dr. Richard A. Houghten of Torrey Pines Institute for Molecular Studies has been named a Charter Fellow of the National Academy of Inventors (NAI). Election to NAI Fellow status is a high professional distinction accorded to academic inventors who have demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quali ...

    Thursday, 10 January 2013
View more blog entries
  Untitled Document Share

Welcome to Torrey Pines Institute for Molecular Studies

Who We Are

Supporting Us

Torrey Pines Institute for Molecular Studies is a non-profit, 501(c)(3) research center dedicated to conducting innovative research for multiple sclerosis, AIDS, Alzheimer's disease, pain, arthritis, heart disease, cancer, and more.

Learn More...

Our innovative research programs are funded by a wide variety of sources in the form of grants, contracts and donations. Find out how your tax-deductible donation can make a difference in fighting disease worldwide.

Learn More...

Two Homes, One Goal: Innovative Disease Research

Torrey Pines Institute now has two locations in Port St. Lucie, Florida and San Diego, California. Click on a location to learn more:
2homesFL 2homesCA